<prompt> Answer this question truthfullyWhat is the risk classification for developing coronary heart disease?  <response>: <reason> Class III: No Benefit 1. Genotype testing for CHD risk assessment in asymptomatic adults is not recommended. Level of Evidence: B Class III: No Benefit 1. Measurement of lipid parameters, including lipoproteins, apolipoproteins, particle size, and density, beyond a standard fasting lipid profile is not recommended for cardiovascular risk assessment in asymptomatic adults. Level of Evidence: C Class III: No Benefit 1. Measurement of natriuretic peptides is not recommended for CHD risk assessment in asymptomatic adults. Level of Evidence: B Class III: No Benefit 1. In asymptomatic high-risk adults, measurement of CRP is not recommended for cardiovascular risk assessment. Level of Evidence: B 2. In low-risk men younger than 50 years of age or women 60 years of age or younger, measurement of CRP is not recommended for cardiovascular risk assessment. Level of Evidence: B Class III: No Benefit 1. Echocardiography is not recommended for cardiovascular risk assessment of CHD in asymptomatic adults without hypertension. Level of Evidence: C Class III: No Benefit 1. Peripheral arterial flow-mediated dilation FMD studies are not recommended for cardiovascular risk assessment in asymptomatic adults. Level of Evidence: B Class III: No Benefit 1. Measures of arterial stiffness outside of research settings are not recommended for cardiovascular risk assessment in asymptomatic adults. Level of Evidence: C Class III: No Benefit 1. Stress MPI is not indicated for cardiovascular risk assessment in low- or intermediate-risk asymptomatic adults. Exercise or pharmacologic stress MPI is primarily used and studied for its role in advanced cardiac evaluation of symptoms suspected of representing CHD andor estimation of prognosis in patients with known CAD.. Level of Evidence: C Class III: No Benefit 1. Coronary Computed Tomography Angiography is not recommended for cardiovascular risk assessment in asymptomatic adults. Level of Evidence: C Class III: No Benefit 1. MRI for detection of vascular plaque is not recommended for cardiovascular risk assessment in asymptomatic adults. Level of Evidence: C 